Eli Lilly and Company (NYSE: LLY) announced today that it will discontinue the Phase 3 rheumatoid arthritis (RA) program for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE